Cantor Fitzgerald


Cantor Fitzgerald Reaffirms Buy On Ebay Ahead Of Release Of 3Q14 Results

In a research report released today, Cantor Fitzgerald analyst Youssef Squali reaffirmed a Buy rating on eBay (NADAQ:EBAY) with a $63 price target …

Ligand: 3Q:14 Guidance Revision Not Likely To Rally Shares Upward, Says Cantor

In a research report sent to investors today, Cantor Fitzgerald analyst Irina Rivkind maintained a Hold rating on Ligand Pharmaceuticals (NASDAQ:LGND) with a $49 price target, as the company updated its 3Q:14 …

Synergy: Medical Conference Expected To Reinforce Investor Interest, Says Cantor

In a research report sent to investors today, Cantor Fitzgerald analyst Irina Rivkind reiterated a Buy rating on Synergy Pharmaceuticals (NASDAQ:SGYP) with a $11 price target, as the …

Cantor Fitzgerald Maintains Buy On Ebay Following Paypal Spinoff

In a research note issued today, Cantor Fitzgerald analyst Youssef Squali maintained a Buy rating on Ebay (NASDAQ:EBAY) with a $63 price target, …

Cantor Fitzgerald Reiterates Buy On Salix Pharma, Increases PT To $181

In a research report published today, Cantor Fitzgerald analyst Irina Rivkind reiterated her Buy rating on Salix Pharma (NASDAQ:SLXP) and increased her price …

Cantor Fitzgerald Remains Bullish On Expedia Following Solid Growth In July And August

In a research note released today, Cantor Fitzgerald analyst Naved Khan maintained a Buy rating on Expedia (NASDAQ:EXPE) with a $92 price target, …

Evoke Pharma: The Stock Now Looks Even More Undervalued, Says Cantor Fitzgerald

In a research note published this morning, Cantor Fitzgerald analyst Irina Rivkind reiterated a Buy rating on Evoke Pharma (NASDAQ:EVOK) with a $20 …

Cantor Fitzgerald Maintains Buy On Philbro Animal Health, Following Solid 4Q FY2014 Revenue

In a research note published today, Cantor Fitzgerald analyst Irina Rivkind maintained a Buy on Phibro Animal Health (NASDAQ:PAHC) with a $27 price target, …

Cantor Fitzgerald Reiterates Sell On Endo Health, Increases PT To $56

In a research note released this morning, Cantor Fitzgerald analyst Irina Rivkind reiterated a Sell rating on Endo Health Solutions (NASDAQ:ENDP) but increased …

Cantor Fitzgerald Maintains Buy On Eagle Pharma As Teva Removes Initial Lawsuit But Files Another One

In a research report released today, Cantor Fitzgerald analyst Irina Rivkind maintained a Buy rating on Eagle Pharma (NASDAQ:EGRX) with a $30 price …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts